Correlation Between VentriPoint Diagnostics and Sirona Biochem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VentriPoint Diagnostics and Sirona Biochem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VentriPoint Diagnostics and Sirona Biochem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VentriPoint Diagnostics and Sirona Biochem Corp, you can compare the effects of market volatilities on VentriPoint Diagnostics and Sirona Biochem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VentriPoint Diagnostics with a short position of Sirona Biochem. Check out your portfolio center. Please also check ongoing floating volatility patterns of VentriPoint Diagnostics and Sirona Biochem.

Diversification Opportunities for VentriPoint Diagnostics and Sirona Biochem

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between VentriPoint and Sirona is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding VentriPoint Diagnostics and Sirona Biochem Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sirona Biochem Corp and VentriPoint Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VentriPoint Diagnostics are associated (or correlated) with Sirona Biochem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sirona Biochem Corp has no effect on the direction of VentriPoint Diagnostics i.e., VentriPoint Diagnostics and Sirona Biochem go up and down completely randomly.

Pair Corralation between VentriPoint Diagnostics and Sirona Biochem

Assuming the 90 days horizon VentriPoint Diagnostics is expected to under-perform the Sirona Biochem. But the stock apears to be less risky and, when comparing its historical volatility, VentriPoint Diagnostics is 1.84 times less risky than Sirona Biochem. The stock trades about 0.0 of its potential returns per unit of risk. The Sirona Biochem Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  12.00  in Sirona Biochem Corp on August 31, 2024 and sell it today you would lose (5.50) from holding Sirona Biochem Corp or give up 45.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

VentriPoint Diagnostics  vs.  Sirona Biochem Corp

 Performance 
       Timeline  
VentriPoint Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Sirona Biochem Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sirona Biochem Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Sirona Biochem showed solid returns over the last few months and may actually be approaching a breakup point.

VentriPoint Diagnostics and Sirona Biochem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VentriPoint Diagnostics and Sirona Biochem

The main advantage of trading using opposite VentriPoint Diagnostics and Sirona Biochem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VentriPoint Diagnostics position performs unexpectedly, Sirona Biochem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sirona Biochem will offset losses from the drop in Sirona Biochem's long position.
The idea behind VentriPoint Diagnostics and Sirona Biochem Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance